Literature DB >> 16307387

A clinical and molecular overview of the human osteopetroses.

W Balemans1, L Van Wesenbeeck, W Van Hul.   

Abstract

The osteopetroses are a heterogeneous group of bone remodeling disorders characterized by an increase in bone density due to a defect in osteoclastic bone resorption. In humans, several types can be distinguished and a classification has been made based on their mode of inheritance, age of onset, severity, and associated clinical symptoms. The best-known forms of osteopetrosis are the malignant and intermediate autosomal recessive forms and the milder autosomal dominant subtypes. In addition to these forms, a restricted number of cases have been reported in which additional clinical features unrelated to the increased bone mass occur. During the last years, molecular genetic studies have resulted in the identification of several disease-causing gene mutations. Thus far, all genes associated with a human osteopetrosis encode proteins that participate in the functioning of the differentiated osteoclast. This contributed substantially to the understanding of osteoclast functioning and the pathogenesis of the human osteopetroses and will provide deeper insights into the molecular pathways involved in other bone pathologies, including osteoporosis.

Entities:  

Mesh:

Year:  2005        PMID: 16307387     DOI: 10.1007/s00223-005-0027-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  37 in total

1.  Role of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking.

Authors:  Subramanya N M Pandruvada; Janie Beauregard; Suzanne Benjannet; Monica Pata; Claude Lazure; Nabil G Seidah; Jean Vacher
Journal:  Mol Cell Biol       Date:  2015-11-23       Impact factor: 4.272

2.  Using osteoclast differentiation as a model for gene discovery in an undergraduate cell biology laboratory.

Authors:  Mark J Birnbaum; Jenna Picco; Meghan Clements; Hanna Witwicka; Meiheng Yang; Margaret T Hoey; Paul R Odgren
Journal:  Biochem Mol Biol Educ       Date:  2010-11       Impact factor: 1.160

Review 3.  Unveiling the mysteries of the genetics of osteoporosis.

Authors:  N Alonso; S H Ralston
Journal:  J Endocrinol Invest       Date:  2014-08-23       Impact factor: 4.256

Review 4.  Human Genetics of Sclerosing Bone Disorders.

Authors:  Raphaël De Ridder; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

5.  Novel mutations of TCIRG1 cause a malignant and mild phenotype of autosomal recessive osteopetrosis (ARO) in four Chinese families.

Authors:  Xiao-Ya Zhang; Jin-Wei He; Wen-Zhen Fu; Chun Wang; Zhen-Lin Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

6.  Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effect.

Authors:  Elena A Bliznetz; Svetlana M Tverskaya; Rena A Zinchenko; Anna V Abrukova; Ekaterina N Savaskina; Maxim V Nikulin; Alexander G Kirillov; Evgeny K Ginter; Alexander V Polyakov
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

7.  A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.

Authors:  Nesrin Besbas; Markus Draaken; Michael Ludwig; Ozgur Deren; Diclehan Orhan; Yelda Bilginer; Fatih Ozaltin
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

Review 8.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

9.  Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II).

Authors:  Zhen-Lin Zhang; Jin-Wei He; Hao Zhang; Wei-Wei Hu; Wen-Zhen Fu; Jie-Mei Gu; Jin-Bo Yu; Gao Gao; Yun-Qiu Hu; Miao Li; Yu-Juan Liu
Journal:  J Bone Miner Metab       Date:  2009-03-14       Impact factor: 2.626

Review 10.  Sclerosing bone disorders: a lot of knowns but still some unknowns.

Authors:  Wim Van Hul
Journal:  Bonekey Rep       Date:  2012-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.